Evidence map›Paper›PMID 23614619›Full record

ReviewCritical reviews in oncogenesis2013

SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers.

Carina Preskill, Joanne B Weidhaas

Abstract readReview
In one paragraph

Review in Critical reviews in oncogenesis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Computational exploration ofBiochemistry and biophysics reports · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Journal of Cancer · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Nefarious Nexus of Noncoding RNAs in Cancer.International journal of molecular sciences · 2018
    Review
  17. Non-coding RNA networks in cancer.Nature reviews. Cancer · 2018
    Review
  18. Article
  19. Article
  20. Focusing the management of rectal cancer.Annals of translational medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carina PreskillDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.
Joanne B Weidhaas

Funding

MicroRNAs to Understand Cause and Outcome in Breast CancerR01CA157749 · NCI · YALE UNIVERSITY · PI SLACK, FRANK J., WEIDHAAS, JOANNE B · 2012 to 2016
$1.7M
NCI NIH HHS R01 CA157749NCI NIH HHS R01CA157749
6 · The paper itself

Abstract

Single-nucleotide polymorphisms within microRNA (miRNA) binding sites comprise a novel genre of cancer biomarkers. Since miRNA regulation is dependent on sequence complementarity between the mRNA transcript and the miRNA, even single-nucleotide aberrations can have significant effects. Over the past few years, many examples of these functional miRNA binding site SNPs have been identified as cancer biomarkers. While most of the research to date focuses on associations with cancer risk, more and more studies are linking these SNPs to cancer prognosis and response to treatment as well. This review summarizes the state of the field and draws importance to this rapidly expanding area of cancer biomarkers.

Indexed as

Binding SitesBiomarkers, TumorHumansMicroRNAsNeoplasmsPolymorphism, Single NucleotidePrognosisBiomarkers, TumorMicroRNAs

Identifiers

PMID23614619
PMCPMC4028830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.